JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bell, D.
Right arrow Articles by McDermott, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bell, D.
Right arrow Articles by McDermott, B. J.

Vol. 303, Issue 2, 581-591, November 2002

Induction of Hypertrophic Responsiveness of Cardiomyocytes to Neuropeptide Y in Response to Pressure Overload

David Bell, Adrian R. Allen, Elizabeth J. Kelso, Ambikaipakan Balasubramaniam and Barbara J. McDermott

Department of Therapeutics and Pharmacology, Centre for Cardiovascular and Genetics Research, School of Medicine, The Queen's University of Belfast, United Kingdom (D.B., A.R.A., E.J.K., B.J.McD.); and Division of Gastrointestinal Hormones, Department of Surgery, University of Cincinnati Medical Center, Cincinnati, Ohio (A.B.)

To determine whether neuropeptide Y (NPY)-related mechanisms become activated with progression of cardiac hypertrophy in vivo, protein mass and de novo protein synthesis (incorporation of [14C]Phe, 0.1 µCi ml-1) were assessed in cardiomyocytes, obtained from spontaneously hypertensive rats (SHRs) and normotensive Wistar Kyoto rats (8, 12, 16, 20, and 24 weeks of age), and cultured for 24 h. NPY (10-8 M) increased protein mass of cardiomyocytes from 16-week-old SHRs by 9.2 ± 2.1% (n = 8, P < 0.05). De novo protein synthesis was increased maximally in SHRs at 12, 16, and 20 weeks (P < 0.05, n = 8) in response to NPY by 12.6 ± 2.1% (10-6 M), 20.1 ± 4.2% (10-8 M), and 9.4 ± 1.8% (10-7 M), respectively. Peptide YY3-36, (PYY3-36), which displays selectivity for NPY Y2 and NPY Y5 receptors, and the NPY Y5-selective agonist [D-Trp34]-NPY increased de novo protein synthesis maximally by 16.2 ± 5.1% (10-7 M; n = 4, P < 0.05) and 17.8 ± 5.2% (10-6 M; n = 7, P < 0.05), respectively, in SHRs at 16 weeks, whereas [Leu31Pro34]-NPY (<= 10-6 M), which displays some activity at NPY Y1 and NPY Y4 receptors, did not. The NPY Y1-selective antagonist BVD-42 (2 × 10-7 M) and the NPY Y2-selective antagonist BIIE0246 (2 × 10-7 M) did not attenuate responses to NPY (10-7 M) and PPY3-36 (10-7 M). These data indicate that hypertrophic responsiveness to NPY, mediated via NPY Y5 receptors, is induced transiently in SHR cardiomyocytes subsequent to onset of cardiomyocyte hypertrophy in response to pressure overload.


0022-3565/02/3032-0581$07.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
A. R. Allen, E. J. Kelso, D. Bell, Y. Zhao, P. Dickson, and B. J. McDermott
Modulation of Contractile Function through Neuropeptide Y Receptors during Development of Cardiomyocyte Hypertrophy
J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1286 - 1296.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
L. Protas, J. Qu, and R. B. Robinson
Neuropeptide Y: Neurotransmitter or Trophic Factor in the Heart?
Physiology, October 1, 2003; 18(5): 181 - 185.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.